These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10756452)

  • 1. [Administration of clarithromycin (CAM) to non-small cell lung cancer].
    Majima T; Mikasa K; Sakamoto M; Hamada K; Konishi M; Maeda K; Yoshimoto E; Murakawa K; Takahashi K; Kita E; Narita N
    Jpn J Antibiot; 2000 Jan; 53 Suppl A():52-5. PubMed ID: 10756452
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fluctuation in the cytokine m-RNA content in primary non-small cell lung cancer caused by clarithromycin (CAM) administration].
    Teramoto S; Kita E; Mikasa K; Hamada K; Konishi M; Maeda K; Sakamoto M; Tsujimoto M; Mori K; Sawaki M; Narita N
    Jpn J Antibiot; 1997 Mar; 50 Suppl A():42-4. PubMed ID: 9597438
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of clarithromycin administration on interferon-gamma and interleukin 12 mRNA expression in the tumor tissue of non-small-cell lung cancer].
    Teramoto S; Kita E; Mikasa K; Hamada K; Konishi M; Maeda K; Sakamoto M; Tsujimoto M; Mori K; Sawaki M; Narita N
    Jpn J Antibiot; 1998 Jan; 51 Suppl A():53-5. PubMed ID: 9597486
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer].
    Sakamoto M; Mikasa K; Hamada K; Konishi M; Maeda K; Yoshimoto E; Ueda K; Majima T; Sawaki M; Kita E; Narita N
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2259-66. PubMed ID: 9881083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of clarithromycin in paitents with unresectable non-small-cell lung cancer--clinical evaluation of those who survived for a long time and those succumbed in a short period].
    Sakamoto M; Mikasa K; Majima T; Konishi M; Maeda K; Yoshimoto E; Murakawa K; Takahashi K; Kita E; Narita N
    Jpn J Antibiot; 2000 Jan; 53 Suppl A():56-9. PubMed ID: 10756453
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of clarithromycin (CAM) in patients with inoperable non-small-cell lung cancer].
    Sakamoto M; Mikasa K; Sawaki M; Hamada K; Teramoto S; Ueta K; Majima T; Konishi M; Maeda K; Tsujimoto M; Mori K; Kita E; Narita N
    Jpn J Antibiot; 1998 Jan; 51 Suppl A():50-2. PubMed ID: 9597485
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of effects and mechanisms of macrolide as biological response modifier for lung cancer treatment].
    Mikasa K
    Jpn J Antibiot; 2000 Apr; 53(4):253-60. PubMed ID: 10868303
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer].
    Ieshiro R; Goto G; Ota T; Yuasa K; Iguchi M; Okamura J
    Jpn J Antibiot; 1997 Mar; 50 Suppl A():49-52. PubMed ID: 9597440
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lung cancer: progress in diagnosis and treatment. IV. Related topics: 2. Macrolides as biological response modifiers for the treatment of lung cancer].
    Mikasa K; Sawaki M; Kita E; Hamada K; Sakamoto M; Teramoto S; Narita N
    Nihon Naika Gakkai Zasshi; 1997 Jan; 86(1):100-7. PubMed ID: 9102408
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy of clarithromycin on cancer cachexia in patients with primary non-small cell lung cancer].
    Sakamoto M; Mikasa K; Hamada K; Teramoto S; Konishi M; Maeda K; Tsujimoto M; Mori K; Sawaki M; Kita E; Narita N
    Jpn J Antibiot; 1997 Mar; 50 Suppl A():38-41. PubMed ID: 9597437
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of antineoplastic effect of CAM (clarithromycin) in a mouse model inoculated with lung cancer cells].
    Hamada K; Sakamoto M; Mikasa K; Teramoto M; Mori K; Tsujimoto M; Maeda K; Konishi M; Sawaki M; Narita N; Kita E
    Jpn J Antibiot; 1997 Mar; 50 Suppl A():28-31. PubMed ID: 9597434
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer--the second report].
    Ieshiro R; Goto G; Ota T; Yuasa K; Iguchi M; Okamura J
    Jpn J Antibiot; 1998 Jan; 51 Suppl A():47-9. PubMed ID: 9597484
    [No Abstract]   [Full Text] [Related]  

  • 13. [Suppression of non-small-cell lung carcinoma metastasis with clarithromycin].
    Sakamoto M; Mikasa K; Majima T; Hamada K; Konishi M; Yoshimoto E; Takahashi S; Narita N; Maeda K; Murakawa K; Kita E
    Jpn J Antibiot; 2001 Feb; 54 Suppl A():40-3. PubMed ID: 11439903
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of clarithromycin on prolonging the life expectancy of patients with primary lung cancer].
    Mikasa K; Sawaki M; Kita E; Hamada K; Sakamoto M; Konishi M; Maeda K; Teramoto S; Tsujimoto M; Mori K; Ueda K; Fukuoka K; Segawa K; Kataoka T; Narita N
    Jpn J Antibiot; 1997 Mar; 50 Suppl A():45-8. PubMed ID: 9597439
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of therapeutic efficacy of clarithromycin in a model for human lung cancer metastasis and a mouse tumor system].
    Yano S; Sone S; Yamagishi T; Akashi T
    Jpn J Antibiot; 1998 Jan; 51 Suppl A():72-4. PubMed ID: 9597491
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of BRM (biological response modifier) action of clarithromycin (CAM)--effect on cytokine expression in a mouse lung cancer model].
    Ueta K; Hamada K; Mikasa K; Teramoto M; Sakamoto S; Konishi M; Maeda K; Tsujimoto M; Mori K; Majima T; Sawaki M; Kita E; Narita N
    Jpn J Antibiot; 1998 Jan; 51 Suppl A():57-60. PubMed ID: 9597487
    [No Abstract]   [Full Text] [Related]  

  • 17. Significant survival benefit to patients with advanced non-small-cell lung cancer from treatment with clarithromycin.
    Mikasa K; Sawaki M; Kita E; Hamada K; Teramoto S; Sakamoto M; Maeda K; Konishi M; Narita N
    Chemotherapy; 1997; 43(4):288-96. PubMed ID: 9209786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of clarithromycin on experimental pulmonary metastasis].
    Kokubo Y; Shibuya M; Hino M; Wagatsuma A; Aoyama S; Matsuda K; Kyo D; Kudo S
    Jpn J Antibiot; 1998 Jan; 51 Suppl A():61-4. PubMed ID: 9597488
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-influenza mechanism of macrolide antibiotics inducing airway IL-12 production in murine influenza model ].
    Shiroki K
    Jpn J Antibiot; 2003 Apr; 56 Suppl A():68-71. PubMed ID: 14679751
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of clarithromycin on experimental pulmonary metastasis].
    Kokubo Y; Shibuya M; Hino M; Azuma A; Aoyama S; Matsuda K; Shu D; Kudo S
    Jpn J Antibiot; 1997 Mar; 50 Suppl A():35-7. PubMed ID: 9597436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.